| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $20.9M | — | +82.8% |
| SG&A Expense | $8.9M | — | +508.8% |
| Operating Income | -$29.9M | — | -131.2% |
| Pre-tax Income | -$27.2M | — | -119.6% |
| Income Tax | $0 | — | — |
| Net Income | -$27.2M | — | -119.6% |
| EPS (Basic) | -$1.32 | — | +93.3% |
| EPS (Diluted) | -$1.32 | — | +93.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $168.4M | +673.7% | — |
| Current Assets | $397.1M | +160.4% | — |
| Total Assets | $397.4M | +160.4% | — |
| Current Liabilities | $6.7M | -26.6% | — |
| Total Liabilities | $6.7M | -26.6% | — |
| Stockholders' Equity | $390.6M | +422.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$21.2M | — | -59.0% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | -$101.3M | — | -543.2% |
| Financing Cash Flow | $269.1M | — | +3095.0% |
| Free Cash Flow | -$21.2M | — | -58.7% |
| +743.9% |